<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://triscience.com/Disease/Antibodies/rss">
  <title>Disease Antibodies</title>
  <link>http://triscience.com</link>

  <description>
    
      An antibody (or also known as an immunoglobulin) is typically a large protein shaped like a Y and is produced by the immune system to recognize and neutralize foreign objects that might do harm on the body (for example, a bacteria or a virus). The antibody can identify the unique part of the foreign matter—an antigen—and lock on the antigen using its Y tips. Each tip of the antibody has a paratrope (a lock-like structure) that corresponds to the epitope (a key-like structure) on the antigen, and when these two structures meet, they will be bonded together. Through this binding mechanism, the antibody tags an infected cell or a microbe for attack by the other components of the immune system. The antibody can also neutralize its target antigen directly—it can block a specific part of the microbe that is important for both its invasion and survival. The humoral immune system is directly responsible for the production of antibodies.

Antibodies are produced by plasma cells, which are a type of white blood cells. There are two physical forms of antibodies: the soluble form secreted by the cell, and a membrane bound form attached to the surface of a B-Cell. This second form is also known as the B-Cell Receptor or BCR. The BCR exclusively occurs on the surface of B-Cells and is known to facilitate the activation of the cells it is bound to. They also activate the subsequent differentiation into plasma cells or memory B-Cells that will survive the immunity process and will “recall” the same antigen. This process is called “immunological memory,” with which the immune system remembers a specific antigen and will respond to it more efficiently in future encounters.

This category contains scientific information on antibodies, which are blood proteins produced by the body in response to a specific disease antigen.
    
  </description>

  

  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2012-06-18T07:39:14Z</syn:updateBase>
        

  <image rdf:resource="http://triscience.com/logo.png"/>

  <items>
    <rdf:Seq>
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-chengjiang-fauna-china-oldest-soft-bodied-fauna-on-earth"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-calibration-of-sulfur-35-or-phosphorus-32-with-carbon-14-labeled-brain-paste-or-carbon-14-plastic-standards-for-quantitative-autoradiography-using-lkb-ultrofilm-or-amersham-hyperfilm"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-biological-and-clinical-significance-of-nicks-in-human-chorionic-gonadotropin-and-its-free-beta-subunit"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-beneficial-and-adverse-effects-of-hypnotics"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-articulatory-kinematics-of-final-lengthening"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-alpha-1-adrenergic-agonist-methoxamine-and-the-loop-diuretic-frusemide-reduce-nasal-potential-difference"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-age-structure-and-growth-dynamics-of-young-of-the-year-bass-dicentrarchus-labrax-populations"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/the-acceptability-of-behavioral-and-emotional-feedback-depending-upon-valence-and-structure-in-personal-growth-groups"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/tethyan-boreal-correlations-and-the-jurassic-cretaceous-boundary"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/testing-optimal-foraging-theory-on-the-radial-maze-the-role-of-learning-in-patch-sampling"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/testing-for-neutral-to-ground-connections-in-new-construction"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/terpenoids-from-crepis-tectorum-molecular-and-crystalline-structure-of-the-sesquiterpene-lactone-8-epideacylcynaropicrin"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/techniques-of-ureteric-reimplantation-in-kidney-transplantation-and-its-related-urological-complications"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/systemic-scleroderma-coexistent-with-discoid-lupus-erythematosus"/>
      
      
        <rdf:li rdf:resource="http://triscience.com/Disease/Antibodies/synthetic-peptides-for-plasmodium-vivax-malaria-sero-epidemiology-application-of-fmoc-polyamide-and-displacement-chromatography"/>
      
    </rdf:Seq>
  </items>

</channel>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-chengjiang-fauna-china-oldest-soft-bodied-fauna-on-earth">
    <title>The chengjiang fauna china oldest soft bodied fauna on earth</title>
    <link>http://triscience.com/Disease/Antibodies/the-chengjiang-fauna-china-oldest-soft-bodied-fauna-on-earth</link>
    <description>The recently discovered Chengjiang fossil fauna from the Lower Cambrian near Kunming in south China is paralleled only by the Middle Cambrian Burgess Shale fauna in British Columbia in its excellent s...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    <dc:date>2013-05-21T01:54:22Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-calibration-of-sulfur-35-or-phosphorus-32-with-carbon-14-labeled-brain-paste-or-carbon-14-plastic-standards-for-quantitative-autoradiography-using-lkb-ultrofilm-or-amersham-hyperfilm">
    <title>The calibration of sulfur 35 or phosphorus 32 with carbon 14 labeled brain paste or carbon 14 plastic standards for quantitative autoradiography using lkb ultrofilm or amersham hyperfilm</title>
    <link>http://triscience.com/Disease/Antibodies/the-calibration-of-sulfur-35-or-phosphorus-32-with-carbon-14-labeled-brain-paste-or-carbon-14-plastic-standards-for-quantitative-autoradiography-using-lkb-ultrofilm-or-amersham-hyperfilm</link>
    <description>The relationship between 14c-labeled brain paste or plastic standards and 35s- or 32p-labeled brain paste was characterized with quantitative autoradiography. Film was exposed to both sets of 14c-labe...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>autoradiographic</dc:subject>
    
    
      <dc:subject>autoradiography</dc:subject>
    
    
      <dc:subject>brain</dc:subject>
    
    
      <dc:subject>densitometry</dc:subject>
    
    
      <dc:subject>hyperfilm</dc:subject>
    
    
      <dc:subject>labeled</dc:subject>
    
    
      <dc:subject>radioactivity</dc:subject>
    
    
      <dc:subject>radioisotypes</dc:subject>
    
    
      <dc:subject>solubilizer</dc:subject>
    
    
      <dc:subject>spectroscopy</dc:subject>
    
    
      <dc:subject>standards</dc:subject>
    
    
      <dc:subject>tissue</dc:subject>
    
    
      <dc:subject>ultrofilm</dc:subject>
    
    <dc:date>2013-05-21T01:54:01Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-biological-and-clinical-significance-of-nicks-in-human-chorionic-gonadotropin-and-its-free-beta-subunit">
    <title>The biological and clinical significance of nicks in human chorionic gonadotropin and its free beta subunit</title>
    <link>http://triscience.com/Disease/Antibodies/the-biological-and-clinical-significance-of-nicks-in-human-chorionic-gonadotropin-and-its-free-beta-subunit</link>
    <description>Human chorionic gonadotropin (hCG) is a glycoprotein hormone composed of two dissimilar subunits,.alpha. and.beta. Nicks or missing peptide linkages have been found in the.beta.44-52 region of the.bet...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>antibodies</dc:subject>
    
    
      <dc:subject>binding</dc:subject>
    
    
      <dc:subject>chorionic</dc:subject>
    
    
      <dc:subject>disease</dc:subject>
    
    
      <dc:subject>elastase</dc:subject>
    
    
      <dc:subject>glycoprotein</dc:subject>
    
    
      <dc:subject>gonadotropin</dc:subject>
    
    
      <dc:subject>hormone</dc:subject>
    
    
      <dc:subject>human</dc:subject>
    
    
      <dc:subject>immunoassays</dc:subject>
    
    
      <dc:subject>immunological</dc:subject>
    
    
      <dc:subject>leucocyte</dc:subject>
    
    
      <dc:subject>leucocytic</dc:subject>
    
    
      <dc:subject>molecules</dc:subject>
    
    
      <dc:subject>myometrial</dc:subject>
    
    
      <dc:subject>peptide</dc:subject>
    
    
      <dc:subject>protease</dc:subject>
    
    
      <dc:subject>receptor</dc:subject>
    
    
      <dc:subject>standards</dc:subject>
    
    
      <dc:subject>steroidogenic</dc:subject>
    
    <dc:date>2013-05-21T01:53:48Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-beneficial-and-adverse-effects-of-hypnotics">
    <title>The beneficial and adverse effects of hypnotics</title>
    <link>http://triscience.com/Disease/Antibodies/the-beneficial-and-adverse-effects-of-hypnotics</link>
    <description>Findings from a four-city study of the beneficial and adverse effects of hypnotics are reported. The study employed a new volunteer call-in method for monitoring drug effects outside of the clinical s...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>clinical</dc:subject>
    
    
      <dc:subject>drug</dc:subject>
    
    
      <dc:subject>flurazepam</dc:subject>
    
    
      <dc:subject>hypnotics</dc:subject>
    
    
      <dc:subject>medication</dc:subject>
    
    
      <dc:subject>medications</dc:subject>
    
    
      <dc:subject>produce</dc:subject>
    
    
      <dc:subject>temazepam</dc:subject>
    
    
      <dc:subject>triazolam</dc:subject>
    
    <dc:date>2013-05-21T01:53:42Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-articulatory-kinematics-of-final-lengthening">
    <title>The articulatory kinematics of final lengthening</title>
    <link>http://triscience.com/Disease/Antibodies/the-articulatory-kinematics-of-final-lengthening</link>
    <description>In order to understand better the phonetic control of final lengthening, the articulation of phrase-final syllables was compared with that of two other contexts known to increase syllable duration: ac...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>intergestural</dc:subject>
    
    
      <dc:subject>intragestural</dc:subject>
    
    
      <dc:subject>kinematics</dc:subject>
    
    
      <dc:subject>syllable</dc:subject>
    
    
      <dc:subject>syllables</dc:subject>
    
    
      <dc:subject>unaccented</dc:subject>
    
    <dc:date>2013-05-21T01:53:25Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-alpha-1-adrenergic-agonist-methoxamine-and-the-loop-diuretic-frusemide-reduce-nasal-potential-difference">
    <title>The alpha 1 adrenergic agonist methoxamine and the loop diuretic frusemide reduce nasal potential difference</title>
    <link>http://triscience.com/Disease/Antibodies/the-alpha-1-adrenergic-agonist-methoxamine-and-the-loop-diuretic-frusemide-reduce-nasal-potential-difference</link>
    <description>"Pretreatment by inhalation with the.alpha.1-adrenergic agonist methoxamine and the ""loop"" diuretic frusemide reduces the bronchial response to certain airway challenges in asthma. To test whether t...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>adrenergic</dc:subject>
    
    
      <dc:subject>agonist</dc:subject>
    
    
      <dc:subject>amiloride</dc:subject>
    
    
      <dc:subject>concentration</dc:subject>
    
    
      <dc:subject>diuretic</dc:subject>
    
    
      <dc:subject>drug</dc:subject>
    
    
      <dc:subject>drugs</dc:subject>
    
    
      <dc:subject>epithelial</dc:subject>
    
    
      <dc:subject>frusemide</dc:subject>
    
    
      <dc:subject>methoxamine</dc:subject>
    
    
      <dc:subject>molcntdot</dc:subject>
    
    
      <dc:subject>salbutamol</dc:subject>
    
    
      <dc:subject>treatment</dc:subject>
    
    
      <dc:subject>water</dc:subject>
    
    <dc:date>2013-05-21T01:53:00Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-age-structure-and-growth-dynamics-of-young-of-the-year-bass-dicentrarchus-labrax-populations">
    <title>The age structure and growth dynamics of young of the year bass dicentrarchus labrax populations</title>
    <link>http://triscience.com/Disease/Antibodies/the-age-structure-and-growth-dynamics-of-young-of-the-year-bass-dicentrarchus-labrax-populations</link>
    <description>Back-calculated egg fertilization (spawned) dates and growth rates for young-of-the-year bass, Dicentrarchus labrax (L), captured from Loughor Estuary, Oxwich Bay and Ogmore Estuary, south Wales, Uk, ...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>dicentrarchus</dc:subject>
    
    
      <dc:subject>environments</dc:subject>
    
    
      <dc:subject>fertilization</dc:subject>
    
    
      <dc:subject>food</dc:subject>
    
    
      <dc:subject>growth</dc:subject>
    
    
      <dc:subject>habitats</dc:subject>
    
    
      <dc:subject>intra</dc:subject>
    
    
      <dc:subject>labrax</dc:subject>
    
    
      <dc:subject>loughor</dc:subject>
    
    
      <dc:subject>nursery</dc:subject>
    
    
      <dc:subject>ogmore</dc:subject>
    
    
      <dc:subject>oxwich</dc:subject>
    
    
      <dc:subject>populations</dc:subject>
    
    
      <dc:subject>realtive</dc:subject>
    
    
      <dc:subject>spawnings</dc:subject>
    
    
      <dc:subject>temperatures</dc:subject>
    
    
      <dc:subject>wales</dc:subject>
    
    
      <dc:subject>water</dc:subject>
    
    <dc:date>2013-05-21T01:52:57Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/the-acceptability-of-behavioral-and-emotional-feedback-depending-upon-valence-and-structure-in-personal-growth-groups">
    <title>The acceptability of behavioral and emotional feedback depending upon valence and structure in personal growth groups</title>
    <link>http://triscience.com/Disease/Antibodies/the-acceptability-of-behavioral-and-emotional-feedback-depending-upon-valence-and-structure-in-personal-growth-groups</link>
    <description>Forty-eight students particpated in a one-time personal growth group. Subjects were assigned to one of eight groups. Exercises were conducted to promote interpersonal contact, followed by feedback ses...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>behavioral</dc:subject>
    
    
      <dc:subject>growth</dc:subject>
    
    
      <dc:subject>particpated</dc:subject>
    
    
      <dc:subject>research</dc:subject>
    
    <dc:date>2013-05-21T01:52:41Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/tethyan-boreal-correlations-and-the-jurassic-cretaceous-boundary">
    <title>Tethyan boreal correlations and the jurassic cretaceous boundary</title>
    <link>http://triscience.com/Disease/Antibodies/tethyan-boreal-correlations-and-the-jurassic-cretaceous-boundary</link>
    <description>The author (1987) was able to determine three-realmally correlatable horizons, which are revalent with respect to the stratigraphic position of the Jurassic-Cretaceous boundary (see Fig. 2): The rock ...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>ammonite</dc:subject>
    
    
      <dc:subject>argentiniceras</dc:subject>
    
    
      <dc:subject>beriasella</dc:subject>
    
    
      <dc:subject>berriasella</dc:subject>
    
    
      <dc:subject>berriasian</dc:subject>
    
    
      <dc:subject>berriasina</dc:subject>
    
    
      <dc:subject>boreal</dc:subject>
    
    
      <dc:subject>buchia</dc:subject>
    
    
      <dc:subject>chetae</dc:subject>
    
    
      <dc:subject>chetaites</dc:subject>
    
    
      <dc:subject>chronostratigraphically</dc:subject>
    
    
      <dc:subject>coquand</dc:subject>
    
    
      <dc:subject>correlatable</dc:subject>
    
    
      <dc:subject>craspedites</dc:subject>
    
    
      <dc:subject>dorbigny</dc:subject>
    
    
      <dc:subject>durangites</dc:subject>
    
    
      <dc:subject>elderensis</dc:subject>
    
    
      <dc:subject>epivirgatites</dc:subject>
    
    
      <dc:subject>eustatic</dc:subject>
    
    
      <dc:subject>fischeriana</dc:subject>
    
    <dc:date>2013-05-21T01:52:25Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/testing-optimal-foraging-theory-on-the-radial-maze-the-role-of-learning-in-patch-sampling">
    <title>Testing optimal foraging theory on the radial maze the role of learning in patch sampling</title>
    <link>http://triscience.com/Disease/Antibodies/testing-optimal-foraging-theory-on-the-radial-maze-the-role-of-learning-in-patch-sampling</link>
    <description>A four-arm radial maze containing 10 feeders in each arm (patch) was used to study patch sampling in rats. In each of three experiments, rats foraged for 30 sessions. On each session, two randomly cho...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>food</dc:subject>
    
    
      <dc:subject>foraged</dc:subject>
    
    
      <dc:subject>foraging</dc:subject>
    
    
      <dc:subject>radial</dc:subject>
    
    
      <dc:subject>rats</dc:subject>
    
    <dc:date>2013-05-21T01:52:19Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/testing-for-neutral-to-ground-connections-in-new-construction">
    <title>Testing for neutral to ground connections in new construction</title>
    <link>http://triscience.com/Disease/Antibodies/testing-for-neutral-to-ground-connections-in-new-construction</link>
    <description>A study was performed to seek out inadvertent connections between neutral and ground in the power distribution system of a newly constructed hospital, prior to occupancy. Such connections are not only...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>misconnections</dc:subject>
    
    <dc:date>2013-05-21T01:52:19Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/terpenoids-from-crepis-tectorum-molecular-and-crystalline-structure-of-the-sesquiterpene-lactone-8-epideacylcynaropicrin">
    <title>Terpenoids from crepis tectorum molecular and crystalline structure of the sesquiterpene lactone 8 epideacylcynaropicrin</title>
    <link>http://triscience.com/Disease/Antibodies/terpenoids-from-crepis-tectorum-molecular-and-crystalline-structure-of-the-sesquiterpene-lactone-8-epideacylcynaropicrin</link>
    <description>Sesquiterpene lactones: isolipidiol and 8-epideacylcynaropicrin, were isolated from the aboveground part of C. tectorum during flowering. The structure of 1r,3s-hydroxy-5r,6r,7r,8r-hydroxy-cis,1trans-...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>aboveground</dc:subject>
    
    
      <dc:subject>epideacylcynaropicrin</dc:subject>
    
    
      <dc:subject>flowering</dc:subject>
    
    
      <dc:subject>guai</dc:subject>
    
    
      <dc:subject>hydroxy</dc:subject>
    
    
      <dc:subject>isolipidiol</dc:subject>
    
    
      <dc:subject>lactones</dc:subject>
    
    
      <dc:subject>olide</dc:subject>
    
    
      <dc:subject>sesquiterpene</dc:subject>
    
    
      <dc:subject>tectorum</dc:subject>
    
    
      <dc:subject>trien</dc:subject>
    
    <dc:date>2013-05-21T01:52:13Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/techniques-of-ureteric-reimplantation-in-kidney-transplantation-and-its-related-urological-complications">
    <title>Techniques of ureteric reimplantation in kidney transplantation and its related urological complications</title>
    <link>http://triscience.com/Disease/Antibodies/techniques-of-ureteric-reimplantation-in-kidney-transplantation-and-its-related-urological-complications</link>
    <description>Two common techniques of ureteric reimplantation for kidney transplantation, the Politano-Leadbetter and the extravesical ureteroneocystostomy are described in detail. Correct techniques of donor uret...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>diagnosis</dc:subject>
    
    
      <dc:subject>extravesical</dc:subject>
    
    
      <dc:subject>fistulae</dc:subject>
    
    
      <dc:subject>harvesting</dc:subject>
    
    
      <dc:subject>leadbetter</dc:subject>
    
    
      <dc:subject>politano</dc:subject>
    
    
      <dc:subject>reimplantation</dc:subject>
    
    
      <dc:subject>stent</dc:subject>
    
    
      <dc:subject>transplantation</dc:subject>
    
    
      <dc:subject>treatment</dc:subject>
    
    
      <dc:subject>ureter</dc:subject>
    
    
      <dc:subject>ureteric</dc:subject>
    
    
      <dc:subject>ureteroneocystostomy</dc:subject>
    
    
      <dc:subject>urinary</dc:subject>
    
    
      <dc:subject>urological</dc:subject>
    
    <dc:date>2013-05-21T01:51:32Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/systemic-scleroderma-coexistent-with-discoid-lupus-erythematosus">
    <title>Systemic scleroderma coexistent with discoid lupus erythematosus</title>
    <link>http://triscience.com/Disease/Antibodies/systemic-scleroderma-coexistent-with-discoid-lupus-erythematosus</link>
    <description>A 46-year-old woman with chilblain like erythema on her cheeks, nose, ears, hands and feet for 2 years was diagnosed as having discoid lupus erythematosus (Dle) with weakly positive serum antinuclear ...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>anti</dc:subject>
    
    
      <dc:subject>antibodies</dc:subject>
    
    
      <dc:subject>antinuclear</dc:subject>
    
    
      <dc:subject>diagnosis</dc:subject>
    
    
      <dc:subject>dieases</dc:subject>
    
    
      <dc:subject>discoid</dc:subject>
    
    
      <dc:subject>disease</dc:subject>
    
    
      <dc:subject>erythema</dc:subject>
    
    
      <dc:subject>erythematosus</dc:subject>
    
    
      <dc:subject>histopathlogy</dc:subject>
    
    
      <dc:subject>lupus</dc:subject>
    
    
      <dc:subject>raynauds</dc:subject>
    
    
      <dc:subject>scleroderma</dc:subject>
    
    
      <dc:subject>serum</dc:subject>
    
    <dc:date>2013-05-21T01:50:37Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>


  <item rdf:about="http://triscience.com/Disease/Antibodies/synthetic-peptides-for-plasmodium-vivax-malaria-sero-epidemiology-application-of-fmoc-polyamide-and-displacement-chromatography">
    <title>Synthetic peptides for plasmodium vivax malaria sero epidemiology application of fmoc polyamide and displacement chromatography</title>
    <link>http://triscience.com/Disease/Antibodies/synthetic-peptides-for-plasmodium-vivax-malaria-sero-epidemiology-application-of-fmoc-polyamide-and-displacement-chromatography</link>
    <description>The immunodominant epitope of Plasmodium vivax, one of the major causative agents of malaria in man, consists of the tandem repetitions of a non apeptide sequence, AspArgAlaAsp/AlaGlyGlnProAlaGly, wit...</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>admin</dc:creator>
    <dc:rights></dc:rights>
    
      <dc:subject>90</dc:subject>
    
    
      <dc:subject>apeptide</dc:subject>
    
    
      <dc:subject>aspargalaaspalaglyglnp</dc:subject>
    
    
      <dc:subject>chromatography</dc:subject>
    
    
      <dc:subject>ddaad</dc:subject>
    
    
      <dc:subject>deblocking</dc:subject>
    
    
      <dc:subject>elisa</dc:subject>
    
    
      <dc:subject>epidemiology</dc:subject>
    
    
      <dc:subject>epidermiology</dc:subject>
    
    
      <dc:subject>epitope</dc:subject>
    
    
      <dc:subject>ethanedithiol</dc:subject>
    
    
      <dc:subject>fmoc</dc:subject>
    
    
      <dc:subject>immunodominant</dc:subject>
    
    
      <dc:subject>malaria</dc:subject>
    
    
      <dc:subject>nonapeptide</dc:subject>
    
    
      <dc:subject>peptide</dc:subject>
    
    
      <dc:subject>peptides</dc:subject>
    
    
      <dc:subject>plasmodium</dc:subject>
    
    
      <dc:subject>polyamide</dc:subject>
    
    
      <dc:subject>polymer</dc:subject>
    
    
      <dc:subject>produce</dc:subject>
    
    <dc:date>2013-05-21T01:50:24Z</dc:date>
    <dc:type>Doculite</dc:type>
  </item>





</rdf:RDF>
